INFINITUM ASSET MANAGEMENT, LLC
FORT LAUDERDALE, FL · CIK 2058093 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2025 · limited liability company
- Assets managed$1.1bn
- Staff5 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 (3 hedge) · $1.1bn gross assets
- Form ADV · 2026-03-31SEC adviser record
- Legal entityINFINITUM ASSET MANAGEMENT, LLC (US)
$983.2m
reported value
+23.0% vs Q1 2026
17positions
92.7%in top 10
1 new
3 added
3 reduced
5 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SEA LTD SE | $201.6m20.50% | Added +702.3k |
| ARRIVENT BIOPHARMA INC AVBP | $154.2m15.68% | Added +289.5k |
| UNITY SOFTWARE INC U | $121.5m12.35% | Unchanged |
| BIOHAVEN LTD BHVN | $93.0m9.46% | Unchanged |
| VERADERMICS INC MANE | $89.9m9.14% | Unchanged |
| TAIWAN SEMICONDUCTOR MFG LTD TSM | $83.6m8.50% | Unchanged |
| GITLAB INC GTLB | $57.2m5.82% | Reduced -72.3k |
| FIGURE TECHNOLOGY SOLUTIO FIGR | $49.1m5.00% | Added +350.0k |
| NVIDIA CORPORATION NVDA | $40.0m4.07% | Unchanged |
| REDDIT INC RDDT | $21.7m2.21% | Unchanged |
| ALPHABET INC GOOG | $17.7m1.80% | Reduced -35.0k |
| AVALYN PHARMACEUTICALS INC AVLN | $13.5m1.38% | New |
| BENITEC BIOPHARMA INC BNTC | $12.3m1.26% | Unchanged |
| AMAZON COM INC AMZN | $11.9m1.21% | Reduced -75.0k |
| MANCHESTER UTD PLC NEW MANU | $8.5m0.86% | Unchanged |
| ARCHER AVIATION INC ACHR | $5.3m0.54% | Unchanged |
| META PLATFORMS INC META | $2.3m0.23% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| APPLOVIN CORP APP | $39.8m100.0k shares |
| COREWEAVE INC CRWV | $11.6m150.0k shares |
| WIX COM LTD WIX | $9.0m100.0k shares |
| TRIPADVISOR INC TRIP | $4.1m380.5k shares |
| SYNOPSYS INC SNPS | $4.0m10.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ARRIVENT BIOPHARMA INC AVBP · 13G · filed 2026-02-17 | 9.9%≈ $143.3m |